Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
INTRODUCTION:Galactose-deficient IgA1 (Gd-IgA1) is a critical pathogenic factor for IgA nephropathy (IgAN), but its value as a disease-specific biomarker remains controversial. We aimed to clarify the clinical significance of Gd-IgA1 in patients with IgAN. METHODS:We retrospectively reviewed 111 pat...
Main Authors: | Yukihiro Wada, Kei Matsumoto, Taihei Suzuki, Tomohiro Saito, Nobuhiro Kanazawa, Shohei Tachibana, Ken Iseri, Motonori Sugiyama, Masayuki Iyoda, Takanori Shibata |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6214568?pdf=render |
Similar Items
-
Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
by: Jin Sug Kim, et al.
Published: (2020-11-01) -
Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
by: Yusuke Fukao, et al.
Published: (2022-06-01) -
cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy.
by: Taro Misaki, et al.
Published: (2023-01-01) -
cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy
by: Taro Misaki, et al.
Published: (2023-01-01) -
Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy
by: Koshi Yamada, et al.
Published: (2020-04-01)